Abstract
Objective
Few studies have investigated potentially inappropriate medication (PIM) use in patients with Alzheimer’s disease (AD). The aim of our study was to assess the prevalence of PIM in community-dwelling patients diagnosed with mild-to-moderate AD and identify the clinical factors associated with PIM prescriptions.
Methods
REAL.FR is a 4-year, prospective, multicenter French cohort of AD patients recruited in centers of expertise. We analyzed patient baseline data at entry into the study. PIMs were assessed using the Laroche list. A multivariate logistic regression was conducted to assess factors associated with PIMs.
Results
A total of 684 AD patients were enrolled in the study [mean age 77.9 ± 6.8 years, 486 (71.0 %) females]. According to the Laroche list, 46.8 % [95 % confidence interval (CI) 43.0–50.5 %] of the patients had at least one PIM. “Cerebral vasodilators” were the most widely used class of PIM, accounting for 24.0 % (95 % CI 20.9–27.3 %) of all prescriptions, followed by atropinic drugs (17.0 %, 95 % CI 14.1–19.8 %) and long half-life benzodiazepines (8.5 %, 95 % CI 6.4–10.6 %). Atropinic drugs were associated with cholinesterase inhibitors in 16 % of patients. In the multivariate analysis, only two factors, namely, female gender [odds ratio (OR) 1.5, 95 % CI 1.1–2.2] and polypharmacy (≥5 drugs; OR 3.6, 95 % CI 2.6–4.5) were associated with prescriptions for PIMs.
Conclusions
These results reveal that approximately one out of two community-dwelling patients with mild-to-moderate AD treated by AD specialists use PIMs. They also indicate that the characteristics of the disease and the pharmacodynamic/pharmacokinetic profile of the drugs prescribed are not sufficiently taken into account by physicians when prescribing for AD patients.
Similar content being viewed by others
References
Viktil KK, Blix HS, Moger TA, Reikvam A (2007) Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 63:187–195
Agence de Sécurité Sanitaire des Produits de Santé (Afssaps) and Réseau Français des Centres Régionaux de Pharmacovigilance (AFCRPV) Etude PEIMA (2011) Prévalence des effets indésirables médicamenteux chez les patients atteints de la maladie d’Alzheimer ou d’un syndrome démentiels. Available at: http://www.chu-montpellier.fr/publication/inter_pub/R361/A7610/RapportPEIMAfinal.pdf
Onder G, Gambassi G, Scales CJ, Cesari M, Vedova CD, Landi F, Bernabei R (2002) Adverse drug reactions and cognitive function among hospitalized older adults. Eur J Clin Pharmacol 58:371–377
Ganjavi H, Herrmann N, Rochon PA, Sharma P, Lee M, Cassel D et al (2007) Adverse drug events in cognitively impaired elderly patients. Dement Geriatr Cogn Disord 23:395–400
Chang CB, Chen JH, Wen CJ, Kuo HK, Lu IS, Chiu LS, Wu SC, Chan DC (2011) Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria. Br J Clin Pharmacol 72:482–489
Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 157:1531–1536
Laroche ML, Charmes JP, Merle L (2007) Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 63:725–731
Holmes HM, Sachs GA, Shega JW, Hougham GW, Cox Hayley D, Dale W (2008) Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. J Am Geriatr Soc 56:1306–1311
Lau DT, Mercaldo ND, Harris AT, Trittschuh E, Shega J, Weintraub S (2010) Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord 24:56–63
Zuckerman IH, Hernandez JJ, Gruber-Baldini AL, Hebel JR, Stuart B, Zimmerman S, Magaziner J (2005) Potentially inappropriate prescribing before and after nursing home admission among patients with and without dementia. Am J Geriatr Pharmacother 3:246–254
Fick D, Kolanowski A, Waller J (2007) High prevalence of central nervous system medications in community-dwelling older adults with dementia over a three-year period. Aging Ment Health 11:588–595
Gillette-Guyonnet S, Nourhashemi F, Andrieu S, Cantet C, Micas M, Ousset PJ, Vellas B, REAL.FR Group (2003) The REAL.FR research program on Alzheimer’s disease and its management: methods and preliminary results. J Nutr Health Aging 7:91–96
Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of ADL: a standardized measure of biological and phychosocial function. JAMA 185:914–919
Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179–186
Rosen WG, Mohs RC, Davis KL (1984) A new rating scale for Alzheimer’s disease. Am J Psychiatry 141:1356–1364
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572
Vellas B, Guigoz Y, Garry PJ, Nourhashemi F, Bennahum D, Lauque S, Albarede JL (1999) The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 15:116–122
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314
Zarit SH, Reever KE, Bach-Peterson J (1980) Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 20:649–655
WHO Collaborating Centre for Drug Statistics Methodology. Available at: http://www.whocc.no/atcddd/
Jyrkkä J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S (2009) Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging 26:1039–1048
Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P, Gallo PF, Carpenter I, Finne-Soveri H, Gindin J, Bernabei R, Landi F, SHELTER Project (2012) Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci 67:698–704
Rédaction Prescrire (2001) Eviter les effets indésirables par interactions medicamenteuses: comprendre et décider. Rev Prescr 31:416
Boustani MA, Campbell NL, Munger S, Maidment I, Fox GC (2008) Impact of anticholinergics on the aging brain: a review and practical application. Aging Health 4:311–320
Campbell N, Boustani M, Limbil T, Ott C et al (2009) The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging 4:225–233
Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163:2716–2724
StataCorp (2009) Stata statistical software: Release 11. StataCorp LP, College Station
Colloca G, Tosato M, Vetrano DL, Topinkova E, Fialova D, Gindin J, van der Roest HG, Landi F, Liperoti R, Bernabei R, Onder G, SHELTER project (2012) Inappropriate drugs in elderly patients with severe cognitive impairment: results from the shelter study. PLoS One 7:e46669
Laroche ML, Charmes JP, Bouthier F, Merle L (2009) Inappropriate medications in the elderly. Clin Pharmacol Ther 85:94–97
Bongue B, Naudin F, Laroche ML, Galteau MM, Guy C, Guéguen R, Convers JP, Colvez A, Maarouf N (2009) Trends of the potentially inappropriate medication consumption over 10 years in older adults in the East of France. Pharmacoepidemiol Drug Saf 18:1125–1133
Laroche ML, Charmes JP, Nouaille Y, Fourrier A, Merle L (2006) Impact of hospitalization in an acute medical geriatric unit on potentially inappropriate medication use. Drugs Aging 23:49–59
Bouvenot G (1999) Consumption and prescription of “cerebral vasodilators” in community AFSSAPS Saint Denis. Available at: http://www.afssaps.fr/var/afssaps_site/storage/original/application/5f7c8b4942b1fc927ad7d2b11f13ddf7.pdf
Nagaraja D, Jayashree S (2001) Randomized study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment. Am J Psychiatry 158:1517–1519
Tavassoli N, Sommet A, Lapeyre-Mestre MP, Bagheri H, Montrastruc JL (2007) Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formulary (Vidal, British National Formulary). Drug Saf 30:1063–1071
Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, Coulton S, Katona C, Boustani MA, Brayne C (2011) Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc 59:1477–1483
Wu CS, Ting TT, Wang SC, Chang IS, Lin KM (2011) Effect of benzodiazepine discontinuation on dementia risk. Am J Geriatr Psychiatry 19:151–159
Boeuf-Cazou O, Bongue B, Ansiau D, Marquié JC, Lapeyre-Mestre M (2011) Impact of long-term benzodiazepine use on cognitive functioning in young adults: the VISAT cohort. Eur J Clin Pharmacol 67:1045–1052
Billioti de Gage S, Bégaud B, Bazin F, Verdoux H, Dartigues JF, Pérès K, Kurth T, Pariente A (2012) Benzodiazepine use and risk of dementia: prospective population based study. Br Med J 345:e6231. doi:10.1136/bmj.e6231
Özdemir V, Fourie J, Busto U, Naranjo CA (1996) Pharmacokinetic changes in the elderly: do they contribute to drug abuse and dependence? Clin Pharmacokinet 31:372–385
Ruggiero C, Dell’Aquila G, Gasperini B, Onder G, Lattanzio F, Volpato S, Corsonello A, Maraldi C, Bernabei R, Cherubini A, ULISSE Study Group (2010) Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging 27:747–758
Weston AL, Weinstein AM, Barton C, Yaffe K (2010) Potentially inappropriate medication use in older adults with mild cognitive impairment. J Gerontol A Biol Sci Med Sci 65:318–321
Lapeyre-Mestre M, Chastan E, Louis A, Montastruc JL (1999) Drug consumption in workers in France: a comparative study at a 10-year interval (1996 versus 1986). J Clin Epidemiol 52:471–478
Fialová D, Topinková E, Gambassi G, Finne-Soveri H, Jónsson PV, Carpenter I, Schroll M, Onder G, Sørbye LW, Wagner C, Reissigová J, Bernabei R, AdHOC Project Research Group (2005) Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 293:1348–1358
Reynish E, Cortes F, Andrieu S, Cantet C, Olde Rikkert M, Melis R, Froelich L, Frisoni GB, Jönsson L, Visser PJ, Ousset PJ, Vellas B, ICTUS Study Group (2007) The ICTUS Study: a prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort. Neuroepidemiology 29:29–38
Acknowledgments
This work was supported by a grant from the Clinical Research Hospital Program from the French Ministry of Health (PHRC No. 98-47N/01-010-01).
REAL.FR Study group:
Principal investigator: Pr. B. Vellas (Toulouse). Associated investigators: Pr. M. Rainfray (Bordeaux), Pr. J.P. Emeriau (Bordeaux), Pr. A. Franco (Grenoble), Pr. F. Pasquier (Lille), Dr. B. Frigard (Lille), Dr. B. Michel (Marseille), Pr. C. Jeandel (Montpellier), Pr. J. Touchon (Montpellier), Pr. P.H. Robert (Nice), Pr. P. Brocker (Nice), Pr. B. Forette (Paris), Dr. L. Lechowski (Paris), Pr. J. Belmin (Paris), Pr. M. Verny (Paris), Pr. F. Forette, Pr. A.S. Rigaud (Paris), Pr. P. Jouanny (Rennes), Dr. S. Belliard (Rennes), Dr. O. Michel (Rennes), Pr. R. Gonthier (Saint Etienne). Study coordinators: S. Gillette-Guyonnet, Pr. F. Nourhashemi, Dr. P.J. Ousset (Toulouse). Epidemiologist: Pr. S. Andrieu (Toulouse). Data Management: C. Cantet (Toulouse).
Conflict of interest
None.
Sponsors and grants
None.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
François Montastruc and Virginie Gardette contributed equally to designing and writing the article, including the references.
Rights and permissions
About this article
Cite this article
Montastruc, F., Gardette, V., Cantet, C. et al. Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs!. Eur J Clin Pharmacol 69, 1589–1597 (2013). https://doi.org/10.1007/s00228-013-1506-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-013-1506-8